Literature DB >> 20238248

Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System.

Deborah A Fisher1, Leah L Zullig, Steven C Grambow, David H Abbott, Robert S Sandler, Robert H Fletcher, Hashem B El-Serag, Dawn Provenzale.   

Abstract

BACKGROUND AND AIMS: The goals of this study are to evaluate determinants of the time in the medical system until a colorectal cancer diagnosis and to explore characteristics associated with stage at diagnosis.
METHODS: We examined medical records and survey data for 468 patients with colorectal cancer at 15 Veterans Affairs medical centers. Patients were classified as screen-detected, bleeding-detected, or other (resulting from the evaluation of another medical concern). Patients who presented emergently with obstruction or perforation were excluded. We used Cox proportional hazards models to determine predictors of time in the medical system until diagnosis. Logistic regression models were used to determine predictors of stage at diagnosis.
RESULTS: We excluded 21 subjects who presented emergently, leaving 447 subjects; the mean age was 67 years and 98% were male, 66% Caucasian, and 43% stage I or II. Diagnosis was by screening for 39%, bleeding symptoms for 27%, and other for 34%. The median times to diagnosis were 73-91 days and were not significantly different by diagnostic category. In the multivariable model for time to diagnosis, older age, having comorbidities, and Atlantic region were associated with a longer time to diagnosis. In the multivariable model for stage-at-diagnosis, only the diagnostic category was associated with stage; the screen-detected category was associated with decreased risk of late-stage cancer.
CONCLUSIONS: Our results point to several factors associated with a longer time from the initial clinical event until diagnosis. This increased time in the health care system did not clearly translate into more advanced disease at diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20238248      PMCID: PMC2864330          DOI: 10.1007/s10620-010-1174-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors.

Authors:  E S Fisher; J E Wennberg; T A Stukel; J S Skinner; S M Sharp; J L Freeman; A M Gittelsohn
Journal:  Health Serv Res       Date:  2000-02       Impact factor: 3.402

2.  Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.

Authors:  M Korsgaard; L Pedersen; H T Sørensen; S Laurberg
Journal:  Colorectal Dis       Date:  2006-10       Impact factor: 3.788

3.  Colonic neoplasia in patients with nonspecific GI symptoms.

Authors:  D A Lieberman; P L de Garmo; D E Fleischer; G M Eisen; B K Chan; M Helfand
Journal:  Gastrointest Endosc       Date:  2000-06       Impact factor: 9.427

4.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

5.  Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival.

Authors:  J Wattacheril; J R Kramer; P Richardson; B D Havemann; L K Green; A Le; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2008-08-08       Impact factor: 8.171

Review 6.  Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer.

Authors:  Maria Ramos; Magdalena Esteva; Elena Cabeza; Joan Llobera; Amador Ruiz
Journal:  Eur J Cancer       Date:  2008-02-12       Impact factor: 9.162

7.  Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.

Authors:  Ziad F Gellad; Daniel Almirall; Dawn Provenzale; Deborah A Fisher
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

8.  Diagnostic yield of colonoscopy based on symptoms.

Authors:  Anders Lasson; Anders Kilander; Per-Ove Stotzer
Journal:  Scand J Gastroenterol       Date:  2008-03       Impact factor: 2.423

9.  The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center.

Authors:  Craig Pepin; Uri Ladabaum
Journal:  Gastrointest Endosc       Date:  2002-09       Impact factor: 9.427

10.  Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis.

Authors:  Hardeep Singh; Kuang Daci; Laura A Petersen; Clyde Collins; Nancy J Petersen; Anila Shethia; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2009-06-23       Impact factor: 10.864

View more
  17 in total

Review 1.  Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review.

Authors:  Mark Corkum; Robin Urquhart; Cynthia Kendell; Fred Burge; Geoffrey Porter; Grace Johnston
Journal:  Cancer Causes Control       Date:  2011-11-20       Impact factor: 2.506

2.  Outcomes research in gastroenterology and endoscopy.

Authors:  Parantap Gupta; Jonathan M Buscaglia
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

3.  Colorectal cancer: what to do when logic and good intentions are not enough.

Authors:  Dennis J Ahnen
Journal:  Dig Dis Sci       Date:  2010-05       Impact factor: 3.199

4.  Diagnostic Evaluation of Patients Presenting to Primary Care with Rectal Bleeding.

Authors:  Sanja Percac-Lima; Lydia E Pace; Kevin H Nguyen; Charis N Crofton; Katharine A Normandin; Sara J Singer; Meredith B Rosenthal; Alyna T Chien
Journal:  J Gen Intern Med       Date:  2018-01-04       Impact factor: 5.128

5.  Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.

Authors:  Melissa R Partin; Diana J Burgess; James F Burgess; Amy Gravely; David Haggstrom; Sarah E Lillie; Sean Nugent; Adam A Powell; Aasma Shaukat; Louise C Walter; David B Nelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-03       Impact factor: 4.254

Review 6.  Defining timeliness in care for patients with lung cancer: a scoping review.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

7.  Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study.

Authors:  Jochim S Terhaar sive Droste; Frank A Oort; René W M van der Hulst; Veerle M H Coupé; Mike E Craanen; Gerrit A Meijer; Linde M Morsink; Otto Visser; Roy L J van Wanrooij; Chris J J Mulder
Journal:  BMC Cancer       Date:  2010-06-28       Impact factor: 4.430

8.  Do diagnostic and treatment delays for colorectal cancer increase risk of death?

Authors:  Sandi L Pruitt; Amy Jo Harzke; Nicholas O Davidson; Mario Schootman
Journal:  Cancer Causes Control       Date:  2013-02-28       Impact factor: 2.506

9.  An examination of racial differences in process and outcome of colorectal cancer care quality among users of the veterans affairs health care system.

Authors:  Leah L Zullig; George L Jackson; Morris Weinberger; Dawn Provenzale; Bryce B Reeve; William R Carpenter
Journal:  Clin Colorectal Cancer       Date:  2013-08-27       Impact factor: 4.481

Review 10.  Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Authors:  Cristina Renzi; Aradhna Kaushal; Jon Emery; Willie Hamilton; Richard D Neal; Bernard Rachet; Greg Rubin; Hardeep Singh; Fiona M Walter; Niek J de Wit; Georgios Lyratzopoulos
Journal:  Nat Rev Clin Oncol       Date:  2019-07-26       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.